% | $
Quotes you view appear here for quick access.

Titan Pharmaceuticals Inc. Message Board

  • proofkorea2002 proofkorea2002 Mar 25, 2013 9:09 AM Flag

    I think some points are being missed

    First, it is not a question of if but when for approval... can the REMS be worked out before the end of April....
    Once approved, we will have the launch and initial sales figs... at the same time, uplisting... Braeburn will work on PAIN..... and get that to market ASAP. then we should get an ROW... Braeburn will announce more apps such as depression...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I was not aware that Braeburn is already partnered on these other applications. Maybe pain because that uses the same rods, maybe ROW but that is a different market. But, I don't think they are partnered on other Proneura apps. like depression etc. It would make sense for Braeburn but if they go that far they may as well buy Titan. Or, I guess it might be that Titan partners them on the whole Proneura stuff and moves on to other ideas? There are some very smart scientists at Titan and perhaps they want their independence as a small bioteck think tank.

3.46-0.38(-9.90%)Feb 8 4:00 PMEST